With the anticipated updates to ICH E6(R3), Quality by Design and Risk Management will be raised to the forefront in Clinical Trials. How will this impact the population and management of the TMF? What TMF practices already point to Quality by Design? How will the use of metrics drive the focus of the quality of the TMF? How are you “designing” your TMF to drive quality? Attend this panel to find out
- 10 ай бұрын
TMF Week 2021 - Day 4 - 1230PM - PANEL: Updates to ICH GCP - How Quality by Design impacts the TMF
- Рет қаралды 37
Пікірлер